Recalls & Warnings February 25, 2017 Radio "Infomercials" for Cognitive and Joint Health Supplements Deceived Consumers, Says FTC On February 22, 2017, the Federal Trade Commission and the Maine Office of the Attorney General announced a complaint the marketers of CogniPrin and FlexiPrin, charging that they made misleading claims about the supplements in radio infomercials deceptively formatted as talk shows
Compounded tirzepatide at Vesta is the same dual GLP-1/GIP receptor agonist, prescribed for medical weight loss with provider-led titration
Im a terrible insurance guy, in that I dont play golf or tennis, and I dont hunt, fish, or ski
Halpern, a senior author of the study and the head of Penn's Division of Stereotactic and Functional Neurosurgery, said in a news release
Our team will work with you to develop a customized weight loss plan using proven, FDA-approved therapies and lifestyle interventions tailored to your individual needs and goals